Filing Details
- Accession Number:
- 0000903423-17-000244
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-03-30 16:11:03
- Reporting Period:
- 2017-03-27
- Filing Date:
- 2017-03-30
- Accepted Time:
- 2017-03-30 16:11:03
- Original Submission Date:
- 2017-03-29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1169987 | Htg Molecular Diagnostics Inc | HTGM | Pharmaceutical Preparations (2834) | X0 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford, Middlesex, X0 TW8 9GS | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-27 | 300,000 | $10.15 | 792,781 | No | 4 | S | Indirect | By S.R. One, Limited |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By S.R. One, Limited |
Footnotes
- Including 43,538 shares of the Issuer's Common Stock deliverable upon the exercise of a warrant that is exercisable at any time at an exercise price of $14.00.
- Shares are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (Reporting Person).